Background: Malignant hyperthermia syndrome is a hereditary pharmacogenetic disorder of skeletal muscle characterized by hypermetabolic state related to the exposure of volatile anesthetic gases or depolarizing muscle relaxants. It is an infre-quent entity that occurs in genetically predisposed individuals, with a very low incidence in pediatrics (1 in 10,000-15,000 anesthetic procedures). Case report: We report a case of malignant hyperthermia related to exposure to sevoflurane during adenoidectomy surgery in a 6-year-old female. The patient presented with tachycardia, hypercapnia, and hyperthermia, requi-ring two successive doses of dantrolene sodium administration, with an adequate response to the treatment. Conclusions: Malignant hyperthermia syndrome is a rare condition in pediatric patients that should be detected in early stages since it is essential to initiate the treatment as soon as possible.
CITATION STYLE
García-Muro, C., Sáenz-Moreno, I., Riaño-Méndez, B., Gutiérrez-Delgado, J. M., Valencia-Ramos, J., & Esteban-Zubero, E. (2020). Síndrome de hipertermia maligna: una patología infrecuente. Boletín Médico Del Hospital Infantil de México, 77(6). https://doi.org/10.24875/bmhim.20000047
Mendeley helps you to discover research relevant for your work.